Diabetologia

, Volume 33, Issue 9, pp 511–514 | Cite as

Magnesium and glucose homeostasis

  • G. Paolisso
  • A. Scheen
  • F. D'Onofrio
  • P. Lefèbvre
Review

Summary

Magnesium is an important ion in all living cells being a cofactor of many enzymes, especially those utilising high energy phosphate bounds. The relationship between insulin and magnesium has been recently studied. In particular it has been shown that magnesium plays the role of a second messenger for insulin action; on the other hand, insulin itself has been demonstrated to be an important regulatory factor of intracellular magnesium accumulation. Conditions associated with insulin resistance, such as hypertension or aging, are also associated with low intracellular magnesium contents. In diabetes mellitus, it is suggested that low intracellular magnesium levels result from both increased urinary losses and insulin resistance. The extent to which such a low intracellular magnesium content contributes to the development of macro- and microangiopathy remains to be established. A reduced intracellular magnesium content might contribute to the impaired insulin response and action which occurs in Type 2 (non-insulin-dependent) diabetes mellitus. Chronic magnesium supplementation can contribute to an improvement in both islet Beta-cell response and insulin action in non-insulin-dependent diabetic subjects.

Key words

Magnesium insulin glucose homeostasis diabetic complications dietary magnesium supplements 

References

  1. 1.
    Levine C, Coburn JW (1984) Magnesium, the mimic/antagonist of calcium. N Engl J Med 19: 1253–1254Google Scholar
  2. 2.
    Aikawa JK (1981) Magnesium: its biological significance. CRC Press, inc, Boca Raton, FloridaGoogle Scholar
  3. 3.
    Flatman PW (1984) Magnesium transport across cell membrane. J Membrane Biol 80: 1–4Google Scholar
  4. 4.
    Lüdi I, Schatzmann HJ (1987) Some properties of a system for sodium-dependent outward movement of magnesium from metabolizing human red blood cells. J Physiol 390: 367–382PubMedGoogle Scholar
  5. 5.
    Greham LA, Caesar JJ, Burger ASV (1960) Gastrointestinal absorption and excretion of 28Mg in man. Metabolism 9: 166–172Google Scholar
  6. 6.
    Danielson BG, Johansson G, Jung B, Ljunghall S, Lundquist H, Molunbourg P (1970) Gastrointestinal magnesium absorption. Kinetic studies with a 28Mg and a simple method for determination of fractional absorption. Miner Electrolyte Metab 2: 116–122Google Scholar
  7. 7.
    Littledike ET, Arnaud DC (1971) The influence of plasma magnesium concentration on calcitonin secretion in pig. Proc Soc Exper Biol Med 136: 1000–1006Google Scholar
  8. 8.
    Gill JR, Bell NH, Barther FC (1967) Effect of parathyroid extract on magnesium excretion in man. J Appl Physiol 22: 136–142PubMedGoogle Scholar
  9. 9.
    Lostroh AJ, Krahl ME (1973) Accumulation in vitro of magnesium and potassium in rat uterus ion pump activity. Bioch Bioph Acta 291: 260–268Google Scholar
  10. 10.
    Lostroh AJ, Krahl ME (1974) Magnesium a second messenger for insulin: ion translocation coupled to transport activity. Adv. Enzyme Regul 12: 73–81CrossRefPubMedGoogle Scholar
  11. 11.
    Paolisso G, Sgambato S, Passariello B, Giugliano D, Scheen AJ, D'Onofrio F, Lefèbvre PJ (1986) Insulin induces opposite changes in plasma and erythrocyte magnesium concentrations in normal man. Diabetologia 29: 644–647PubMedGoogle Scholar
  12. 12.
    Reinhart RA (1988) Magnesium metabolism: a review with special reference to the relationship between intracellular content and serum levels. Arch Intern Med 148: 2415–2420CrossRefPubMedGoogle Scholar
  13. 13.
    Cohen L, Kitzes R (1983) Magnesium sulfate and digitalis-toxic arrhythmias. JAMA 249: 2808–2810PubMedGoogle Scholar
  14. 14.
    Dyckner T, Wester PO (1978) The relation between extraand intracellular electrolytes in patients with hypokalemia and/or diuretic treatment. Acta Med Scand 204: 269–282PubMedGoogle Scholar
  15. 15.
    Mather HM, Nisbet JA, Burton GH, Pasten GJ, Bland JM, Bailey PA, Pilkington TRE (1979) Hypomagnesaemia in diabetes. Clin Chim Acta 95: 235–242CrossRefPubMedGoogle Scholar
  16. 16.
    Fujii S, Takemura T, Wada M, Akai T, Okuda K (1982) Magnesium levels in plasma, erythrocyte and urine in patients with diabetes mellitus. Horm Metab Res 14: 161–162PubMedGoogle Scholar
  17. 17.
    Vanroelen WF, Van Gaal LF, Van Rooy PE, De Leeuw IH (1985) Serum and erythrocyte magnesium levels in type I and type II diabetics. Acta Diabetol Lat 22: 185–190PubMedGoogle Scholar
  18. 18.
    Sjögren A, Floren CH, Nilsson A (1988) Magnesium, potassium, and zinc deficiency in subjects with type II diabetes mellitus. Acta Med Scand 224: 461–465PubMedGoogle Scholar
  19. 19.
    Sonui H, Robin AH (1978) Membrane bound and cellular cationic changes associated with insulin stimulation of cultured cells. J Cell Physiol 96: 265–278PubMedGoogle Scholar
  20. 20.
    Tonyai S, Motto C, Rayssiguer Y, Heaton FW (1985) Erythrocyte membrane in magnesium deficiency. Am J Nutr 4: 399 AbstractGoogle Scholar
  21. 21.
    Moles KW, McMullen JK (1982) Insulin resistance and hypomagnesaemia: case report. Br Med J 285: 262Google Scholar
  22. 22.
    Durlach J, Rayssiguer Y (1983) Magnésium et glucides I. Données cliniques et thérapeutiques. Magnesium 2: 192–224Google Scholar
  23. 23.
    Fink RI, Kolterman OG, Griffin J, Olefsky JM (1983) Mechanisms of insulin resistance in aging. J Clin Invest 71: 1523–1535PubMedGoogle Scholar
  24. 24.
    Rowe JW, Minaker KL, Pallotta JA, Flier JS (1983) Characteristics of the insulin resistance of aging. J Clin Invest 71: 1581–1587PubMedGoogle Scholar
  25. 25.
    Ferrannini E, Buzzigoli G, Bonadonna R, Giorico MA, Oleggini M, Graziadei L, Pedrinelli R, Brandi L, Bevilacqua S (1987) Insulin resistance in essential hypertension. N Engl J Med 317: 350–357PubMedGoogle Scholar
  26. 26.
    Paolisso G, Passariello N, Sgambato S, Torella R, Buoninconti R, Varricchio M, D'Onofrio F (1987) Impaired insulin-mediated erythrocyte magnesium accumulation in essential hypertension. Clin Sci 73: 535–539PubMedGoogle Scholar
  27. 27.
    Paolisso G, Sacchettino A, Sgambato S, Gentile S, Varricchio M, D'Onofrio F (1988) Impaired insulin-mediated erythrocyte magnesium accumulation in the elderly. Diab Nutr Metab 1: 215–219Google Scholar
  28. 28.
    Elin RJ (1980) Role of magnesium in membrane erythrocyte and platelet function and stability. In: Cantin M and Seelig MS (Eds) Magnesium in health and diseases. Spectrum Press, New York, pp 113–133Google Scholar
  29. 29.
    Londono JH, Rosenbloom AL (1971) Serum calcium and magnesium levels after glucagon in children with diabetes. Diabetes 20 [Suppl 1]: 365 AbstractGoogle Scholar
  30. 30.
    Rosenbloom AL (1977) Serum calcium and magnesium decline during oral glucose tolerance testing in children and adolescent with preclinical diabetes mellitus less than normal. Metabolism 26: 1033–1039CrossRefPubMedGoogle Scholar
  31. 31.
    McNair P, Christensen MS, Christiansen C, Modshod S, Transbol IB (1982) Renal hypomagnesaemia in human diabetes mellitus: its relation to glucose homeostasis. Eur J Clin Invest 12: 81–85PubMedGoogle Scholar
  32. 32.
    Ponder SW, Brouhard BH, Travis LB (1990) Hyperphosphaturia and hypermagnesuria in children with IDDM. Diab Care 13: 437–441Google Scholar
  33. 33.
    Seelig MS, Heggtveit HA (1974) Magnesium interrelationship in ischemic heart disease: a review. Am J Clin Nutr 27: 59–79PubMedGoogle Scholar
  34. 34.
    Mather HM, Levin GE, Nisbet JA (1982) Hypomagnesaemia and ischemic heart disease in diabetes. Diab Care 5: 452–463Google Scholar
  35. 35.
    Paolisso G, Tirelli A, Coppola L, Verrazzo G, Pizza G, Sgambato S, D'Onofrio F (1989) Magnesium administration reduces platelet hyperaggregability in NIDDM. Diab Care 12: 167–168Google Scholar
  36. 36.
    Paolisso G, Sgambato S, Giugliano D, Torella R, Varricchio M, Scheen AJ, D'Onofrio F, Lefèbvre PJ (1988) Impaired insulin-induced erythrocyte magnesium accumulation is correlated to impaired insulin-mediated glucose disposal in Type 2 (non-insulindependent) diabetic patients. Diabetologia 31: 910–915CrossRefPubMedGoogle Scholar
  37. 37.
    Kolterman OG, Gray RS, Griffin J, Burstein P, Insel J, Scarlett JA, Olefsky JM (1981) Receptor and post-receptor defects contribute to the insulin resistance in non-insulin dependent diabetes mellitus. J Clin Invest 68: 957–969Google Scholar
  38. 38.
    Paolisso G, Passariello N, Pizza G, Marrazzo G, Giunta R, Sgambato S, Varricchio M, D'Onofrio F (1989) Dietary magnesium supplements improve B-cell response to glucose and arginine in elderly non-insulin dependent diabetic subjects. Acta Endocrinol 121: 16–20PubMedGoogle Scholar
  39. 39.
    Paolisso G, Sgambato S, Pizza G, Passariello N, Varricchio M, D'Onofrio F (1989) Improved insulin response and action by chronic magnesium administration in aged NIDDM subjects. Diab Care 12: 265–269Google Scholar
  40. 40.
    Legrand C, Okitolonda W, Pottier AM, Lederer J, Henquin JC (1987) Glucose homeostasis in magnesium-deficient rats. Metabolism 36: 160–164Google Scholar
  41. 41.
    Curry DL, Joy RM, Holley DC, Bennett LL (1977) Magnesium modulation of glucose-induced insulin secretion by the perfused rat pancreas. Endocrinology 101: 203–208PubMedGoogle Scholar

Copyright information

© Springer-Verlag 1990

Authors and Affiliations

  • G. Paolisso
    • 1
  • A. Scheen
    • 3
  • F. D'Onofrio
    • 2
  • P. Lefèbvre
    • 3
  1. 1.Istituto di Gerontologia e Geriatria, Terapia Medica e Malattie del MetabolismoUniversity of NaplesNaplesItaly
  2. 2.Istituto di Medicina Generale, Terapia Medica e Malattie del MetabolismoUniversity of NaplesNaplesItaly
  3. 3.Division of Diabetes, Nutrition and Metabolic Disorders, Department of MedicineUniversity of LiègeLiègeBelgium

Personalised recommendations